<unk>  is a monoclonal antibody that is FDA approved for the treatment of squamous cell carcinoma of the head and neck (SCCHN), and K-Ras Mutation-negative,EGFR-expressing colorectal cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include acneiform eruption,  dry skin, pruritus, radiation dermatitis, rash, hypomagnesemia, weight decreasing, constipation, diarrhea, nausea, neutropenia, infectious disease, asthenia, headache, sensory neuropathy, dyspnea, fatigue, late effect of radiation and pain.
Cetuximab
Necitumumab
Panitumumab
Afatinib
Neratinib
Dasatinib
Dabrafenib mesylate
Axitinib